Company / Financials
TransMedics Group, Inc. Financials
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableRevenue
$605.5M
FY2025 · +37.1% YoY
Net Income
$190.3M
FY2025 · +436.6% YoY
Profit Margin
31.4%
FY2025 · net income / revenue
ROE
40.2%
FY2025 · return on equity
Total Assets
$1.1B
FY2025
Total Debt
-
FY2025
Equity
$473.1M
FY2025
ROA
17.8%
FY2025 · return on assets
Statement paths
Metric history
Revenue HistoryTotal revenue from operations$605.5M+37.1% YoYNet Income HistoryProfit after all expenses and taxes$190.3M+436.6% YoYGross Profit HistoryRevenue minus cost of goods sold$362.8M+38.4% YoYCost of Revenue HistoryDirect costs of producing goods and services sold$242.7M+35.2% YoYOperating Income HistoryProfit from core business operations before interest and taxes$108.6M+189.6% YoYSG&A Expense HistorySelling, general, and administrative expenses$185.2M+9.8% YoYR&D Expense HistoryResearch and development spending$69.1M+23.4% YoYInterest Expense HistoryCost of borrowing and debt obligations$10.8MIncome Tax HistoryTotal income tax expense-$82.8M-26292.7% YoYEPS (Basic) HistoryBasic earnings per share-$0.77+37.4% YoY